Picard Medical, Inc.
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The compa… Read more
Picard Medical, Inc. (PMI) - Total Liabilities
Latest total liabilities as of September 2025: $5.55 Million USD
Based on the latest financial reports, Picard Medical, Inc. (PMI) has total liabilities worth $5.55 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Picard Medical, Inc. - Total Liabilities Trend (2022–2024)
This chart illustrates how Picard Medical, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Picard Medical, Inc. Competitors by Total Liabilities
The table below lists competitors of Picard Medical, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MAG Holdings Berhad
KLSE:0095
|
Malaysia | RM496.75 Million |
|
Stellar Resources Limited
PINK:SLROF
|
USA | $1.24 Million |
|
Korchip
KQ:126730
|
Korea | ₩11.41 Billion |
|
Siam Pan Group PCL
BK:SPG
|
Thailand | ฿457.05 Million |
|
Scilex Holding Company
NASDAQ:SCLX
|
USA | $455.60 Million |
|
Ganesh Benzoplast Limited
NSE:GANESHBE
|
India | ₹1.81 Billion |
|
Home Federal Bancorp Louisiana
NASDAQ:HFBL
|
USA | $563.70 Million |
Liability Composition Analysis (2022–2024)
This chart breaks down Picard Medical, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.52 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Picard Medical, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Picard Medical, Inc. (2022–2024)
The table below shows the annual total liabilities of Picard Medical, Inc. from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $35.84 Million | +140.13% |
| 2023-12-31 | $14.93 Million | +266.64% |
| 2022-12-31 | $4.07 Million | -- |